These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8250440)

  • 21. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine].
    Moulia-Pelat JP; Spiegel A; Excler JL; Martin P; Roux JF; Boutin JP; Blondeau C; Saliou P
    Sante; 1996; 6(1):11-5. PubMed ID: 8612008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of hepatitis B: evaluation of two different vaccinal schedules in newborns from HBsAg negative mothers.
    Belloni C; Orsolini P; Martinetti M; Chirico G; Cerbo RM; Comolli G; Maccarini U; Barlassina C; Togni C; Polatti F
    New Microbiol; 1993 Jul; 16(3):237-44. PubMed ID: 8366819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants].
    Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):483-9. PubMed ID: 1482565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
    Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
    Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
    Kulkarni PS; Raut SK; Patki PS; Phadke MA; Jadhav SS; Kapre SV; Dhorje SP; Godse SR
    Vaccine; 2006 Apr; 24(17):3457-60. PubMed ID: 16530299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
    Kang G; Ma F; Chen H; Yang Y; Guo S; Wang Z; Liang X; Li L; Cui F; Zhang L
    Vaccine; 2015 Aug; 33(33):4093-9. PubMed ID: 26144895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against hepatitis B virus in children and adolescents in a pediatric hospital.
    Catania G; Di Ciommo V; Concato C
    Recenti Prog Med; 1996 Jun; 87(6):271-4. PubMed ID: 8766952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
    Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low rates of seroconversion after hepatitis B vaccination in orphanges with high prevalence of virus carriers.
    Cernescu C; Ruţă S; Diaconu C; Bleotu C; Grancea C; Truică C; Crăciun D; Nedelcu IN
    Rom J Virol; 1998; 49(1-4):73-81. PubMed ID: 10892428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term immunogenicity and efficacy of recombinant yeast derived hepatitis B vaccine for interruption of mother-infant transmission of hepatitis B virus.
    Zhu QR; Gu XH; Duan SC; Xu HF
    Chin Med J (Engl); 1994 Dec; 107(12):915-8. PubMed ID: 7882730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Field trial of the Cuban recombinant vaccine against hepatitis B (Heberbiovac HB). Study in newborn infants born to AgsHB+ mothers].
    Galbán García E; Bravo González JR; Castañeda Guillot C; Toledo Curbelo G; González Griego A; Delgado González MG
    Rev Cubana Med Trop; 1992; 44(2):149-57. PubMed ID: 9768208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].
    Liang Z; Li C; Jing Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates.
    Meheus A; Alisjahbana A; Vranckx R; Sukadi A; Usman A; Ngantung W; Sugita E; Safary A; André F; Reniers J
    Postgrad Med J; 1987; 63 Suppl 2():139-41. PubMed ID: 3317350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
    Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
    J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.